Siemens Healthineers Receives FDA Premarket Approval of HCV Genotyping Test for Hepatitis C Patients
New test provides improved accuracy in identification of HCV genotype and subtype for guiding selection of optimal therapeutic treatment for individuals with Hepatitis C